Cannabis use among hospitalized young people experiencing a first episode of psychosis: a case control study

被引:0
作者
Paz Castaneda, Carmen [1 ]
Maria Alliende, Luz [2 ]
Iruretagoyena, Barbara [2 ]
Nachar, Ruben [1 ,3 ]
Mancilla, Felipe [1 ]
Diaz, Camila [1 ]
Gallardo, Carlos [1 ,4 ]
Mena, Cristian [1 ]
Pablo Ramirez-Mahaluf, Juan [2 ]
Undurraga, Juan [1 ,5 ]
Gonzalez-Valderrama, Alfonso [1 ,3 ]
Crossley, Nicolas A. [2 ]
机构
[1] Inst Psiquiatr J Horwitz Barak, Programa Intervenc Temprana, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Escuela Med, Dept Psiquiatria, Santiago, Chile
[3] Univ Finis Terrae, Escuela Med, Santiago, Chile
[4] Univ Diego Portales, Clin Psicol, Santiago, Chile
[5] Univ Desarrollo, Clin Alemana, Fac Med, Dept Neurol & Psiquiatria, Santiago, Chile
关键词
Cannabis; Case-Control Studies; Psychotic Disorders; SCHIZOPHRENIA; RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cannabis use among young people in Chile has increased significantly in the last years. There is a consistent link between cannabis and psychosis. Aim: To compare cannabis use in patients with a first episode of psychosis and healthy controls. Material and Methods: We included 74 patients aged 20 +/- 3 years (78% males) admitted to hospital with a first episode of psychosis and a group of 60 healthy controls aged 23 +/- 4 years (63% males). Cannabis consumption was assessed, including age of first time use and length of regular use. Results: Patients with psychosis reported a non-significantly higher frequency of life-time cannabis use. Patients had longer periods of regular cannabis use compared with healthy subjects (Odds ratio [OR] 2.4; 95% confidence intervals [CI] 1.14-5.05). Patients also used cannabis for the first time at an earlier age (16 compared with 17 years, p < 0.0). The population attributable fraction for regular cannabis use associated with hospital admissions due to psychosis was 17.7% (95% CI 1.2-45.5%). Conclusions: Cannabis use is related to psychosis in this Chilean group of patients. This relationship is stronger in patients with early exposure to the drug and longer the regular use. One of every five admissions due to psychosis is associated with cannabis consumption. These data should influence cannabis legislation and the public policies currently being discussed in Chile.
引用
收藏
页码:1606 / 1613
页数:8
相关论文
共 50 条
  • [31] First-episode of cannabis-induced psychosis in a young adult
    Solis, M. O.
    Valverde Barea, M.
    Soldado Rodriguez, L.
    EUROPEAN PSYCHIATRY, 2020, 63 : S389 - S389
  • [32] Adversity in childhood/adolescence and premorbid tobacco, alcohol, and cannabis use among first-episode psychosis patients
    Langlois, Stephanie
    Zern, Adria
    Kelley, Mary E.
    Compton, Michael T.
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (05) : 1335 - 1342
  • [33] Pre-morbid Conduct Disorder symptoms are associated with cannabis use among individuals with a first episode of psychosis
    Malcolm, Charlotte P.
    Picchioni, Marco M.
    DiForti, Marta
    Sugranyes, Gisela
    Cooke, Elizabeth
    Joseph, Candice
    McQueen, Grant
    Paparelli, Alessandra
    Stilo, Simona
    O'Connor, Jennifer
    Morgan, Craig
    Murray, Robin M.
    Hodgins, Sheilagh
    SCHIZOPHRENIA RESEARCH, 2011, 126 (1-3) : 81 - 86
  • [34] Vitamin D deficiency in first episode psychosis: A case-control study
    Crews, Matthieu
    Lally, John
    Gardner-Sood, Poonam
    Howes, Oliver
    Bonaccorso, Stefania
    Smith, Shubulade
    Murray, Robin M.
    Di Forti, Marta
    Gaughran, Fiona
    SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 533 - 537
  • [35] Cannabis use and psychosis among patients hospitalized in psychiatric wards in Lebanon: a retrospective chart review
    Pia Maria Ghanimé
    Zeinab Bazzi
    Joseph Kazan
    Ghassan Bou Saba
    Samer El Hayek
    Halim Saad
    Farid Talih
    Middle East Current Psychiatry, 30
  • [36] Treatment Settings and Metabolic MONITORING for People Experiencing First-Episode Psychosis
    Batscha, Catherine
    Schneiderhan, Mark E.
    Kataria, Yachana
    Rosen, Cherise
    Marvin, Robert W.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2010, 48 (09) : 44 - 49
  • [37] Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study
    Trotta, Giulia
    Rodriguez, Victoria
    Quattrone, Diego
    Spinazzola, Edoardo
    Tripoli, Giada
    Gayer-Anderson, Charlotte
    Freeman, Tom P.
    Jongsma, Hannah E.
    Sideli, Lucia
    Aas, Monica
    Stilo, Simona A.
    La Cascia, Caterina
    Ferraro, Laura
    La Barbera, Daniele
    Lasalvia, Antonio
    Tosato, Sarah
    Tarricone, Ilaria
    D'Andrea, Giuseppe
    Tortelli, Andrea
    Schuerhoff, Franck
    Szoeke, Andrei
    Pignon, Baptiste
    Selten, Jean-Paul
    Velthorst, Eva
    de Haan, Lieuwe
    Llorca, Pierre-Michel
    Rossi Menezes, Paulo
    Del Ben, Cristina M.
    Luis Santos, Jose
    Arrojo, Manuel
    Bobes, Julio
    Sanjuan, Julio
    Bernardo, Miquel
    Arango, Celso
    Kirkbride, James B.
    Jones, Peter B.
    Richards, Alexander
    Rutten, Bart P.
    Van Os, Jim
    Austin-Zimmerman, Isabelle
    Li, Zhikun
    Morgan, Craig
    Sham, Pak C.
    Vassos, Evangelos
    Wong, Chloe
    Bentall, Richard
    Fisher, Helen L.
    Murray, Robin M.
    Alameda, Luis
    Di Forti, Marta
    PSYCHOLOGICAL MEDICINE, 2023, 53 (15) : 7375 - 7384
  • [38] Coping strategies in carers of young people with a first episode of psychosis
    Cotton, S. M.
    McCann, T. V.
    Gleeson, J. F.
    Crisp, K.
    Murphy, B. P.
    Lubman, D. I.
    SCHIZOPHRENIA RESEARCH, 2013, 146 (1-3) : 118 - 124
  • [39] Sexual risk behaviour in young people with first episode psychosis
    Brown, Adrienne
    Lubman, Dan I.
    Paxton, Susan
    EARLY INTERVENTION IN PSYCHIATRY, 2010, 4 (03) : 234 - 242
  • [40] Cannabis use and cognitive functions in at-risk mental state and first episode psychosis
    Bugra, H.
    Studerus, E.
    Rapp, C.
    Tamagni, C.
    Aston, J.
    Borgwardt, S.
    Riecher-Roessler, A.
    PSYCHOPHARMACOLOGY, 2013, 230 (02) : 299 - 308